Lundbeck Vortioxetine FC tablets
PDF Leaflet Revision Date: January 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of major depressive disorder and relapse prevention.
Dosage (summary)
Starting dose: 10 mg once daily; may adjust to 5-20 mg based on response.
Special Populations
- Elderly: Start at 5 mg
- Renal impairment: No adjustment needed
- Hepatic impairment: No adjustment needed
- Paediatric: Not established for <18 years
Pregnancy & Breastfeeding
Not recommended during pregnancy or breastfeeding; potential risks to newborns.
Key Drug Interactions
- MAOIs: Contraindicated
- CYP2D6 inhibitors: May require dose adjustment
- Serotonergic drugs: Risk of serotonin syndrome
Contraindications
- Hypersensitivity to vortioxetine
- Concomitant use with MAOIs
Common side effects
- Nausea
- Dizziness
- Headache
- Diarrhoea
- Dry mouth
Counselling Points
- Monitor for suicidal thoughts
- Avoid abrupt discontinuation
- Caution when driving or operating machinery
Serious warnings
- Increased risk of suicidal thoughts in young adults
- Risk of serotonin syndrome
- Caution in patients with seizures
Important Disclaimer
The Lundbeck Vortioxetine FC tablets professional information leaflet below is the property of H Lundbeck and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
